239
Participants
Start Date
April 20, 2018
Primary Completion Date
January 31, 2020
Study Completion Date
January 31, 2020
2-stage screen
Pap smear is currently the standard of care for cervical cancer screening in Botswana. In this study, participants will undergo HPV DNA testing at the time of Pap smear collection. If HPV DNA test is positive, they will be referred for colposcopy. Patients who have an HPV negative test but positive Pap smear will be referred for colposcopy per Botswana cervical cancer screening guidelines.
Princess Marina Hospital, Gaborone
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Beth Israel Deaconess Medical Center
OTHER